DCTH Delcath Systems
- 5.470
- +0.070+1.30%
Delcath Systems News
Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride
Delcath Systems (DCTH) said in a regulatory filing Friday it signed a fifth amendment to the license, supply and contract manufacturing agreement with Synerx Pharma and Mylan Teoranta to supply the co
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2023 Earnings Call Transcript
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Delcath Systems Price Target Raised to $20.00/Share From $18.00 by HC Wainwright & Co.
Delcath Systems Price Target Raised to $20.00/Share From $18.00 by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $20
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems with a Buy and raises the price target from $18 to $20.
Delcath Systems Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/27/2024 338.6% HC Wainwright & Co. $18 → $20 Maintains Buy 09/07/2023 360.53% Canaccord Genuity $18 → $
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)
Delcath Systems, Inc. Under ESG Spotlight: Navigating New Compliance Challenges and Financial Implications
Earnings Call Summary | Delcath Systems(DCTH.US) Q4 2023 Earnings Conference
The following is a summary of the Delcath Systems Inc (DCTH) Q4 2023 Earnings Call Transcript:Financial Performance:Delcath Systems Inc. ended Q4 2023 with $32.5 million in cash and investments.Revenu
Delcath Systems Inc (DCTH) Reports Mixed Year-End Financials Amidst Strategic Advancements
Earnings Flash (DCTH) DELCATH SYSTEMS Reports Q4 Revenue $539,000, Vs. Street Est of $550,000
07:43 AM EDT, 03/26/2024 (MT Newswires) -- Earnings Flash (DCTH) DELCATH SYSTEMS Reports Q4 Revenue $539,000, vs. Street Est of $550,000
Delcath Systems Boosts 2024 Treatment Site Activation Guidance to 20 Sites >DCTH
Delcath Systems Boosts 2024 Treatment Site Activation Guidance to 20 Sites >DCTH
Delcath Systems GAAP EPS of -$0.48, Revenue of $0.54M
Delcath Systems Q4 GAAP EPS $(0.48) Beats $(0.51) Estimate, Sales $539.00K Miss $540.00K Estimate
Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.51) by 5.88 percent. This is a 44.19 percent increase over losses of $(0.8
Delcath Systems 4Q Loss/Shr 48c >DCTH
Delcath Systems 4Q Loss/Shr 48c >DCTH
Press Release: Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PR Newswire QUEENSBURY, N.Y., March 26, 2024 Increases 2024 Treatment Site Activation Guidance to 20 S
Earnings Scheduled For March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. • AIM ImmunoTech (AMEX:AIM) is estimated to report
Earnings Preview: Delcath Systems
Delcath Systems (NASDAQ:DCTH) is set to give its latest quarterly earnings report on Tuesday, 2024-03-26. Here's what investors need to know before the announcement.Analysts estimate that Delcath Syst
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
Analysis
Price Target
No Data
